维普中文期刊产品整合服务
420篇 您的检索式:作者名="Nikolsky E"
    题名 作者 年代 出处 被引量
1Contrast -induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables显示文摘Dangas G Inkovou I Nikolsky E 2005Am J Cardiol2005,95,:1
2A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation显示文摘Mehran R Aymong ED Nikolsky E 2004J Am Coil Cardiol2004,44,7:1
3Functional analysis of OMICs data and small molecule compounds in an integrated 'knowledge-based' platform显示文摘Nikolsky Y Kirillow E Zuev R 2009Methods Mol Biol2009,563,:1
4Low hematocrit predicts contrastinduced nephropathy after percutaneous coronary intervention显示文摘Nikolsky E Mehran R Lasic Z 2005Kidney Int2005,67,6:1
5Low hematocrit predicts contrast- induced nephropathy after pereutaneous coronary interventions 显示文摘Nikolsky E Mehran R Lasic Z 2005Kid- ney Int2005,67,2:1
6Contrast-induced nephropathy:definition,epidemiology,and patients at risk显示文摘Mehran R Nikolsky E 0,,100:1
7Drug-eluting stents in the treatment of intermediate lesions:pooled analysis from four randomized trials显示文摘Moses JW Stone GW Nikolsky E 2006J Am Coll Cardiol2006,47,11:1
8Contrast- induced nephropathy after percutaneous coronary interventions in relation to chronic kidIley disease and hernodynamic variables 显示文摘Dangas G Iakovou I Nikolsky E 2005Am J Cardiol2005,95,:1
9Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome 显示文摘Abergel E Nikolsky E 2010Vasc Health Risk Manag2010,6,:1
10Contrast-induced nephropathy:definition,epidemiology,and patients at risk显示文摘Mehran R Nikolsky E 2006Kidney Int Suppl2006,,100:1
11Impact of chronic kidney disease on prognosis of patients with diabetes tes mellitus treated with percutaneous coronary intervention显示文摘Nikolsky E Mehran R Turcot D 2004Am J Cardiol2004,94,3:1
12A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention; development and initial validation显示文摘Mehran R Aymong E D Nikolsky E 2004J Am Coll Cardiol2004,44,7:1
13Low hematocrit predicts contrast-induced nephropathy after percutane- ous coronary interentions显示文摘Nikolsky E Mehran R Lasic Z 2005Kidney Int2005,67,:1
14A simple risk score for predic- tion of contrast-induced nephropathy after percutaneous coronary interven- tion :development and initial validation 显示文摘Mehran R Aymong ED Nikolsky E 2004J Am Coil Cardio12004,44,7:1
15Impact of chronic kid-ney disease on prognosis with diabetes mellitus treated with percutaneous coronary intervention显示文摘Nikolsky E Mehran R Turcot D et a1 2004Am J Cardiol2004,94,3:1
16Radiocontrast nephropathy;identifying the high-risk patient and the implications exacerbating renal, function 显示文摘Nikolsky E Aymong ED Dangas G 2003Rev Cardiovasc Med2003,4,1:1
17A simple risk score for prediction of contrast-induced nephropathy after pereutaneous coronary intervention: development and initial validation显示文摘MEHRAN R AYMONG E D NIKOLSKY E 2004J Am Coil Cardiol2004,44,7:1
18Ticagrelur: an investigational oral anti- platelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome 显示文摘Abergel E Nikolsky E 2010Vasc Health Risk Manag2010,6,:1
19Contrast-induced nepropathy and hehy after percutaneous coronary interventions in relation to chronic kidney disease hemodynamic variables 显示文摘Pangas G Iakovou I Nikolsky E 2005AmJcardiol2005,95,1:1
20Impact of baseline platelet count in patients undergoing primary percutaneous coronary in- tervention in acute myocardial infarction:from the CADILLAC tri- al显示文摘Nikolsky E Grines CL Cox DA et a 2007Am J Cardioh2007,99,:1
返回顶部 每页显示:
共21页 首页 上一页 第1页 下一页 末页 /21 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费